BCLI – brainstorm cell therapeutics inc. (US:NASDAQ)
Stock Stats
News
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing
Form 10-Q BRAINSTORM CELL THERAPEU For: Sep 30
Form 8-K BRAINSTORM CELL THERAPEU For: Nov 14
Form SC 13G BRAINSTORM CELL THERAPEU Filed by: ARMISTICE CAPITAL, LLC
Form SC 13G BRAINSTORM CELL THERAPEU Filed by: Ruck Matthew J
Form 8-K BRAINSTORM CELL THERAPEU For: Oct 29
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.